Stocks · Korea
048530
KOSDAQ
iNtRON Biotechnology
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W-1.39%
1M+1.07%
3M+17.36%
6M-30.05%
1Y-29.18%
YTD-11.94%
52W high7,010원
52W low2,250원
From 52W high-59.49%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 140억 | -15억 | 57억 | -10.6% |
| 2023 | 96억 | -33억 | -97억 | -34.3% |
| 2024 | 64억 | -52억 | -26억 | -81.6% |
| 2025 | 57억 | -79억 | -90억 | -137.7% |
| Quarterly | ||||
| 2024 3Q | 12억 | -16억 | -13억 | -135.1% |
| 2024 4Q | 15억 | -13억 | -15억 | -88.1% |
| 2025 1Q | 12억 | -18억 | -20억 | -155.0% |
| 2025 2Q | 12억 | -20억 | -11억 | -159.5% |
| 2025 3Q | 16억 | -21억 | -17억 | -127.3% |
| 2025 4Q | 17억 | -20억 | -41억 | -119.8% |
Company
Address: 경기도 성남시 중원구 사기막골로 137 중앙인더스피아 5차 701~704호
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-30주요사항보고서(전환사채권발행결정) Major
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.